A West Virginia jury has awarded a retired bakery worker $155,000 in an Actos bladder cancer lawsuit, finding that the maker of the controversial diabetes drug, Takeda Pharmaceuticals, destroyed evidence necessary for the plaintiff to prove that side effects of Actos caused him to develop bladder cancer. The case is the latest in a series of Actos lawsuits filed against Takeda over allegations that the drug company failed to warn consumers and healthcare providers about the risk of bladder cancer linked to Actos. In the Actos lawsuit recently filed by Richard Myers, it was also alleged that Takeda Pharmaceuticals intentionally destroyed documents regarding the alleged link between Actos and bladder cancer side effects.
Concerns about a potential connection between the use of Actos and bladder cancer complications were first raised in 2010, at which point thousands of drug injury lawsuits were filed across the country, on behalf of former Actos users who were diagnosed with bladder cancer or other injuries. In the eighth Actos case to go to before a jury, and the fifth resulting in a verdict for the plaintiff, the West Virginia jury found that Takeda failed to preserve important evidence regarding the potential connection between Richard Myers’ Actos use and his bladder cancer diagnosis, awarding the former bakery worker compensatory damages in the amount of $155,000.
In addition to Actos bladder cancer complaints pending in various state courts across the country, Takeda Pharmaceuticals faces more than 3,500 Actos lawsuits that have been consolidated before U.S. District Judge Rebecca Doherty in the Western District of Louisiana, as part of an MDL (multidistrict litigation). All of the Actos complaints raise similar allegations that Takeda withheld important information about the potential link between Actos and bladder cancer side effects, with many also accusing the drug maker of acting in bad faith and failing to preserve critical documents relevant to the Actos bladder cancer cases, even though Takeda was aware of pending litigation.
As more information comes to light about the alleged link between Actos and bladder cancer, Actos lawyers throughout the United States are investigating claims filed on behalf of former Actos users who have been diagnosed with the potentially deadly disease. If you believe you have been adversely affected by side effects of Actos, such as bladder cancer, our consumer advocates at the Consumer Justice Foundation can help. We are committed to protecting the rights of consumers harmed by side effects of dangerous pharmaceutical drugs, and can help put you in touch with a knowledgeable product liability lawyer who has experience handling Actos bladder cancer claims.
The federal judge presiding over all Actos bladder cancer lawsuits has denied a request by Eli Lilly and Takeda Pharmaceuticals to overturn a $9 billion award for damages returned in the first of thousands of federal Actos cases to go to trial earlier this year. In April, a federal jury ruled that the drug companies should pay Terrance Allen and his wife $1.5 million in compensatory damages and $9 billion in punitive damages, stemming from the drug makers’ failure to provide adequate warnings about the connection between Actos and bladder cancer side effects. If you took Actos in the past, and you have since been diagnosed with bladder cancer, contact a knowledgeable Actos bladder cancer attorney today to explore your possible compensation options.
The punitive damage award returned in the Allen’s bladder cancer trial was one of the largest ever in a pharmaceutical drug liability lawsuit, and was designed to punish Eli Lilly and Takeda for recklessly endangering the lives of consumers by concealing important information about the cancer risks associated with Actos use. Takeda filed post-trial motions seeking to overturn the Actos bladder cancer verdict, arguing that the ruling was “so excessive as to per se demonstrate passion and prejudice.” In an order issued on August 28, Judge Doherty denied the motion, indicating that the jury “acted within its role and discretion to attach whatever weight and make whatever reasonable inference it deemed appropriate when assessing the defendants’ conduct.”
The Allen’s Actos bladder cancer case was the first “bellwether” trial held before U.S. District Judge Rebecca Doherty, who is presiding over more than 3,500 Actos bladder cancer cases that have been consolidated for pretrial proceedings as part of a multidistrict litigation (MDL). The claims have all been centralized in the U.S. District Court for the Western District of Louisiana for coordinated pretrial proceedings, and a series of early “bellwether” trial dates have been scheduled to help the parties gauge how juries are likely to respond to certain testimony and evidence that may be repeated throughout the Actos bladder cancer litigation.
Although Actos became one of the most popular diabetes drug following its approval in 1999, concerns began to emerge as early as 2010 regarding the potential link between Actos and bladder cancer, and thousands of product liability lawsuits have been filed against Takeda and Eli Lilly in the years since. If you believe you have been adversely affected by bladder cancer side effects of Actos, our consumer advocates at the Consumer Justice Foundation can help. We are dedicated to protecting the rights of consumers harmed by dangerous pharmaceutical drugs, and can help put you in touch with a reputable Actos bladder cancer lawyer today.